Llwytho...
Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance
Type 2 diabetes is characterized by elevated serum glucose levels and altered lipid metabolism, due to peripheral insulin resistance and defects of insulin secretion by the pancreatic β-cells. While some cases of obesity and Type 2 diabetes result from genetic dysfunction, the increased worldwide in...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2010
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4122297/ https://ncbi.nlm.nih.gov/pubmed/21428801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.10.264 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|